BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 15922251)

  • 21. The activity of PS-15 in combination with sulfamethoxazole.
    Yeo AE; Rieckmann KH
    Trop Med Parasitol; 1994 Jun; 45(2):136-7. PubMed ID: 7939165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs.
    Hyde JE
    Microbes Infect; 2002 Feb; 4(2):165-74. PubMed ID: 11880048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfection studies to explore essential folate metabolism and antifolate drug synergy in the human malaria parasite Plasmodium falciparum.
    Wang P; Wang Q; Aspinall TV; Sims PF; Hyde JE
    Mol Microbiol; 2004 Mar; 51(5):1425-38. PubMed ID: 14982635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance to sulphadrug-based antifolate therapy in malaria: are we looking in the right place?
    Platteeuw JJ
    Trop Med Int Health; 2006 Jun; 11(6):804-8. PubMed ID: 16772001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folate metabolism in human malaria parasites--75 years on.
    Müller IB; Hyde JE
    Mol Biochem Parasitol; 2013 Mar; 188(1):63-77. PubMed ID: 23500968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of drug resistance in malaria.
    Cowman AF
    Aust N Z J Med; 1995 Dec; 25(6):837-44. PubMed ID: 8770361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on anti-folate antimalarials in east Africa.
    Ortelli F; Maxwell CA; Curtis J; Watkins WM
    Parassitologia; 1999 Sep; 41(1-3):313-4. PubMed ID: 10697874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basis for antifolate action and resistance in malaria.
    Yuthavong Y
    Microbes Infect; 2002 Feb; 4(2):175-82. PubMed ID: 11880049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional analysis of genes encoding enzymes of the folate pathway in the human malaria parasite Plasmodium falciparum.
    Nirmalan N; Wang P; Sims PF; Hyde JE
    Mol Microbiol; 2002 Oct; 46(1):179-90. PubMed ID: 12366841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folate metabolism pathway and Plasmodium falciparum malaria infection in pregnancy.
    Chango A; Abdennebi-Najar L
    Nutr Rev; 2011 Jan; 69(1):34-40. PubMed ID: 21198633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria.
    Karema C; Imwong M; Fanello CI; Stepniewska K; Uwimana A; Nakeesathit S; Dondorp A; Day NP; White NJ
    Antimicrob Agents Chemother; 2010 Jan; 54(1):477-83. PubMed ID: 19841150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel pfdhps haplotypes among imported cases of Plasmodium falciparum malaria in the United Kingdom.
    Sutherland CJ; Fifer H; Pearce RJ; bin Reza F; Nicholas M; Haustein T; Njimgye-Tekumafor NE; Doherty JF; Gothard P; Polley SD; Chiodini PL
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3405-10. PubMed ID: 19433569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancer.
    Nduati E; Diriye A; Ommeh S; Mwai L; Kiara S; Masseno V; Kokwaro G; Nzila A
    Parasitol Res; 2008 May; 102(6):1227-34. PubMed ID: 18259776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization.
    Wang P; Read M; Sims PF; Hyde JE
    Mol Microbiol; 1997 Mar; 23(5):979-86. PubMed ID: 9076734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicases - feasible antimalarial drug target for Plasmodium falciparum.
    Tuteja R
    FEBS J; 2007 Sep; 274(18):4699-704. PubMed ID: 17824956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast.
    Cortese JF; Plowe CV
    Mol Biochem Parasitol; 1998 Aug; 94(2):205-14. PubMed ID: 9747971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand.
    Wilairatana P; Kyle DE; Looareesuwan S; Chinwongprom K; Amradee S; White NJ; Watkins WM
    Ann Trop Med Parasitol; 1997 Mar; 91(2):125-32. PubMed ID: 9307653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The resistance of falciparum malaria in Africa to 4-aminoquinolines and antifolates.
    Schapira A
    Scand J Infect Dis Suppl; 1990; 75():1-64. PubMed ID: 2100881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Insights into Antimalarial Chemopreventive Activity of Antifolates.
    Pethrak C; Posayapisit N; Pengon J; Suwanakitti N; Saeung A; Shorum M; Aupalee K; Taai K; Yuthavong Y; Kamchonwongpaisan S; Jupatanakul N
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0153821. PubMed ID: 34930029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adaptive copy number evolution in malaria parasites.
    Nair S; Miller B; Barends M; Jaidee A; Patel J; Mayxay M; Newton P; Nosten F; Ferdig MT; Anderson TJ
    PLoS Genet; 2008 Oct; 4(10):e1000243. PubMed ID: 18974876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.